News

First Horizon Sees Stock Target Increase After Strong Q3 Earnings

First Horizon Sees Stock Target Increase After Strong Q3 Earnings

First Horizon Stock Target Raised on Positive Earnings News

First Horizon National (NYSE: FHN) has recently received an upward adjustment in its stock price target, as Stephens updated it from $18.00 to $20.00. This change comes on the heels of First Horizon's impressive operating earnings per share (EPS) report, which recorded a value of $0.42. This figure not only surpassed the consensus estimate of $0.37 but also exceeded Stephens' own prediction of $0.38.

Furthermore, the company's core pre-provision net revenue (PPNR) rose above expectations, achieving $335 million compared to a forecast of $330.5 million by the analysts on Wall Street, and coming in ahead of Stephens' estimate of $326.5 million. These promising numbers signal that First Horizon is capitalizing on its operational strengths, enhancing its appeal to current and potential investors.

Positive Trends in Core Income Streams

While the net interest income (NII) was reported to be slightly lower than the projected consensus by a marginal amount, this was balanced out by impressive core fees, particularly stemming from better-than-expected results in fixed income dealings. These factors contributed about $0.01 to the EPS. Additionally, core expenses were slightly below expectations, which bodes well for the company's overall financial health.

Looking to the future, analysts from Stephens predict that the trends displayed will likely continue. They expect the softness in NII to be offset by improved performance in fees and expenses. Their projections for the fourth quarter of 2024 align closely with the midpoint of First Horizon's revenue guidance, illustrating a modest forecast of a 1.2% increase year-over-year, compared to the company's own range of flat to a slight rise.

Long-Term Outlook Remains Strong

Stephens also anticipates that expenses will fall within the higher end of First Horizon's provided forecast of 4% to 6%, predicting a 5.8% increase year-over-year. They maintain their EPS estimate of $1.47 for 2025 while mentioning the potential for growth should First Horizon meet its PPNR targets. For 2026, they have increased their EPS estimate from $1.75 to $1.80 due to favorable trends in fees and expenses.

As a result, the firm has reiterated its Overweight rating for First Horizon's stock, reflecting their positive assessment based on current financial indicators. This supportive outlook is vital for investors looking for stable growth potential in the banking sector.

Recent Upgrades and Broader Market Outlook

In addition to Stephens' uplift, First Horizon National Corporation recently garnered attention from Citi, which has also upgraded its target for the bank to $20, prompted by consistent growth patterns exhibited in their operations. This adjustment took place following an evaluation of the bank's third-quarter performance and financial standing as of the end of the period.

The financial report disclosed a rise in adjusted EPS to $0.42, reflecting a $0.06 increase compared to the previous quarter. Moreover, their pre-provision net revenue demonstrated notable growth, rising by $11 million in the same period. Citi's analysis pointed to the bank's robust financial structures, suggesting that despite facing potential weaknesses in net interest income as interest rates stabilize, First Horizon's varied income sources and strong positioning in economically flourishing regions will sustain its growth trajectory.

Future Opportunities Amid Challenges

Management at First Horizon is looking ahead to a promising landscape, anticipating positive growth in adjusted pre-provision net revenue for 2025 while aspiring to surpass the $100 billion asset threshold. Nevertheless, they acknowledge the likelihood of moderate margin contraction stemming from the repricing of loans and deposits, indicating that careful navigation will be essential in the coming periods.

Despite experiencing strong deposit growth propelled by nearly $1 billion in client acquisition, the bank recognizes that loan growth has been somewhat restrained due to varied market factors. These elements illustrate the dynamic environment in which First Horizon Corporation operates, underscoring the importance of adaptability in its strategy moving forward.

InvestingPro Insights on First Horizon

Recent insights from InvestingPro offer an analytical perspective on the outlook for First Horizon National (NYSE: FHN). The bank boasts a market capitalization of approximately $9.25 billion, with a P/E ratio of 12.13, suggesting an appealing valuation relative to competitors in the banking industry. This rationale aligns with Stephens’ continuing endorsement of an Overweight rating for the stock.

Notably, FHN has maintained its dividend payments over the past 14 years, a factor likely to attract income-conscious investors. The stock is currently trading near its 52-week high and has generated a robust return of 66.68% over the preceding year, reflecting strong investor confidence in the company’s operational success and potential for future growth.

Frequently Asked Questions

What does the upgrade to $20.00 indicate?

The upgrade to $20.00 reflects analysts' confidence in First Horizon's future earnings potential based on their strong recent performance.

How did First Horizon perform in the last quarter?

First Horizon reported an EPS of $0.42, which exceeded analyst expectations, along with a PPNR of $335 million.

What are the main drivers of First Horizon's financial performance?

Positive trends in core fees and controlled expenses have significantly contributed to First Horizon's robust financial performance.

What is the outlook for First Horizon's stock?

The stock is expected to perform well with a significant target increase and supportive ratings from analysts based on growth expectations.

How does First Horizon's financial strength compare to competitors?

First Horizon's strong financial metrics, such as an improved CET1 ratio of 11.2%, position it favorably against peers in the banking sector.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Lifeway Foods Set to Announce Q3 2026 Financial Results

Updated Category News Views 55

Anticipating Lifeway Foods’ Q3 Results Dust off your calendars and mark November 12, 2026—because that's when Lifeway Foods is putting its cards on the table for the third quarter. Nothing like a results call to see if your investments are eating right. NASDAQ:LWAY is no stranger to making some noise in the dairy aisle, thanks to their kefir—that fermented probiotic...

Continue Reading
LifeStance Expands Access to Esketamine, TMS

Updated Category News Views 53

LifeStance Health's Treatment Innovations Today, the spotlight is on LifeStance Health, as they're making waves with their treatment approaches for those battling stubborn, treatment-resistant depression. This isn't your run-of-the-mill attempt at tackling the beast—that familiar indifference masked as hope. No, this time around, they’re swinging with Esketamine and...

Continue Reading
CopperWood Senior Living Revives Historic Campus

Updated Category News Views 55

A Fresh Start for Peapack-Gladstone's Corporate Relic Dust off the pages of history—Peapack-Gladstone's old Pfizer/Beneficial Finance campus is getting a makeover, and boy, it’s not your run-of-the-mill renovation. We're talking adaptive reuse to the tune of nearly $200 million, morphing this architectural gem into CopperWood Senior Living. With all the office...

Continue Reading
Nicely Network: A Game-Changer for B2B SaaS Marketing

Updated Category News Views 173

Navigating the Reddit Marketing Labyrinth Life ain't a walk in the park for marketers these days, especially in the tech and SaaS arenas. Some folks seem to have cracked the code—or at least one part of it. Enter Nicely Network, which has just snagged the crown as the Best Reddit Marketing Agency for B2B SaaS & Software Companies, thanks to its knack for connecting...

Continue Reading
AI Literacy Framework Unfolds at AAC&U Conference

Updated Category News Views 30

Diverse Institutions Converge on AI Literacy A university conference isn't exactly where you'd expect seismic shifts, but this one's a bit of a dark horse. When big names like University of Phoenix, Boise State, Johns Hopkins, and the Medical University of South Carolina start syncing up their AI strategies, it feels like the sector's quietly brewing something big. At the...

Continue Reading
Hanwha's Big Bet: Tokenizing Real-World Assets with Chainlink

Updated Category News Views 15

Hanwha and Chainlink: A Game Changer in Tokenization What do Hanwha Investment & Securities, a heavyweight in Korea's finance scene, and Chainlink, the wizard of onchain finance, think they're up to? They're buddies now, locked and loaded, to tokenize real-world assets (RWAs). They're not just shaking hands; they're aiming to jiggle the global finance bedrock....

Continue Reading
Ruizhi Unveils Trio of High-Tech Paper Bag Machines

Updated Category News Views 21

Cutting-Edge Unveiling at All in Print China 2026 In the bustling expo halls of the Shanghai New International Expo Centre, Ruizhi Machinery rolled out the red carpet for its latest inventions, stealing the limelight at the All in Print China 2026. Now, these were not your run-of-the-mill paper bag makers; we're talking about a set of machines that could redefine the gig...

Continue Reading
Xerox Faces Probes After $130M Profit Forecast Slash

Updated Category News Views 45

When the Trust Breaks October 29, 2026 was a gut punch for Xerox investors. Watching the outlook dive by $130 million, the coffee-feeling in the trading rooms turned into something more bitter. A $105 million boost they once celebrated from tariff receivables now seems to be a fleeting shadow, as Xerox itself scuttles its adjusted operating income for 2026 to a range of...

Continue Reading
Tiny Fish Revolutionizes Vertebrate Gene Studies

Updated Category News Views 41

From Small Fish to Big Discoveries: Meet Danionella cerebrum Who would've thought a diminutive fish with a see-through body would give a jolt to the study of vertebrate genomes? Thanks to Danionella cerebrum, researchers at the Whitehead Institute have created the very first complete whole-body single-cell atlas of an adult vertebrate. Forget the Wall Street clamor for a...

Continue Reading
Instacart's Strong Q3 Amid DoorDash Acquisition News

Updated Category News Views 85

Bumper Profits and Bold Moves for Instacart Here's a twist in the grocery tech aisle—Instacart's got some hefty numbers rolling in for Q3 and a whopper of an acquisition announcement. What seemed like just another Tuesday in the market is shaken by Instacart's reveal of their third-quarter financial results, showcasing a significant year-over-year climb that would make...

Continue Reading

Top 5 Most Recently Viewed Articles

Urban Edge and TruGolf Collaborate on Exciting New Center

Updated Category News Views 241

Urban Edge Partners with TruGolf for Exciting New Venture Urban Edge Properties (NYSE: UE) has taken a significant step in enhancing the entertainment landscape by collaborating with TruGolf, a notable player in the high-tech golf simulator market. This partnership will bring a state-of-the-art TruGolf Links Center to life, offering a unique "eatertainment" experience for...

Continue Reading
Lightbridge Corporation Updates on Q3 2024 Financial Performance

Updated Category News Views 158

Lightbridge Corporation Reports Third Quarter 2024 Results Lightbridge Corporation (NASDAQ: LTBR), renowned for advancing nuclear fuel technology, recently shared its financial outcomes for the third quarter, along with insights into its ongoing initiatives. Growth in Clean Energy Demand CEO Seth Grae highlighted a substantial upswing in clean energy demand sparked by...

Continue Reading
UTSA and UT Health San Antonio Join Forces for Better Impact

Updated Category News Views 316

UTSA and UT Health San Antonio Merger Overview In a significant step for higher education, UTSA and The University of Texas Health Science Center at San Antonio have merged, resulting in the formation of The University of Texas at San Antonio (UT San Antonio). This new institution emerges as the third-largest public research university in Texas, following prestigious...

Continue Reading
Lansinoh Unveils Innovative NaturalWave Pump for New Moms

Updated Category News Views 149

Lansinoh Revolutionizes Breastfeeding with New Pump Launch ALEXANDRIA, Va. — Lansinoh®, a brand dedicated to breastfeeding and maternal care for over four decades, has announced an exciting new product aimed at supporting new mothers. The NaturalWave® Double Electric Breast Pump offers an innovative solution, addressing key challenges faced by moms during their...

Continue Reading
Thermosome Advances in Phase I Trial, Marks Key Milestone for THE001

Updated Category News Views 177

Thermosome Progresses to Final Dose Level in Phase I Trial Thermosome, a leading drug development firm specializing in targeted cancer therapies, has reached a significant milestone by advancing to dose level 3 (DL3) in its ongoing Phase I trial of its lead compound, THE001. This development follows a favorable assessment from the independent Data Safety Monitoring Board...

Continue Reading